Literature DB >> 2730866

Amphotericin B induced ocular toxicity in cryptococcal meningitis.

P K Li1, K N Lai.   

Abstract

We report a case of acute visual loss after a test dose (1 mg) of intravenous amphotericin B administered to a patient with systemic lupus erythematosus and with cryptococcal meningitis. Her visual acuity was normal prior to the injection of amphotericin B. The meningitis subsequently responded to miconazole and flucytosine treatment. Our findings suggest that amphotericin B should be withheld in the treatment of cryptococcal meningitis if disease of the optic nerve is strongly suspected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730866      PMCID: PMC1041751          DOI: 10.1136/bjo.73.5.397

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  OPHTHALMOLOGIC COMPLICATIONS OF CRYPTOCOCCAL MENINGITIS.

Authors:  E OKUN; W T BUTLER
Journal:  Arch Ophthalmol       Date:  1964-01

2.  The improved prognosis of cryptococcal meningitis with amphotericin B therapy.

Authors:  A SPICKARD; W T BUTLER; V ANDRIOLE; J P UTZ
Journal:  Ann Intern Med       Date:  1963-01       Impact factor: 25.391

3.  Treatment of fungal meningitis with miconazole.

Authors:  S C Deresinski; R B Lilly; H B Levine; J N Galgiani; D A Stevens
Journal:  Arch Intern Med       Date:  1977-09

4.  Successful treatment of cerebral cryptococcoma and meningitis with miconazole.

Authors:  L Weinstein; I Jacoby
Journal:  Ann Intern Med       Date:  1980-10       Impact factor: 25.391

  4 in total
  2 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.

Authors:  Lakshmi B Ramamurthy; Ridhi Bhandari; Savitha Kanakpur; P Thejaswini
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.